Antibiotic Therapy in Acute Pancreatitis: from Global Overuse to Evidence Based Recommendations
Andrea Parniczky,Tamas Lantos,Eszter Margit Toth,Zsolt Szakacs,Szilard Godi,Roland Hagendorn,Dora Illes,Balazs Koncz,Katalin Marta,Alexandra Miko,Dora Mosztbacher,Balazs Csaba Nemeth,Daniel Pecsi,Aniko Szabo,Akos Szucs,Peter Varju,Andrea Szentesi,Erika Darvasi,Balint Eross,Ferenc Izbeki,Laszlo Gajdan,Adrienn Halasz,Aron Vincze,Imre Szabo,Gabriella Par,Judit Bajor,Patricia Sarlos,Jozsef Czimmer,Jozsef Hamvas,Minas Takacs,Zoltan Szepes,Laszlo Czako,Marta Varga,Janos Novak,Barnabas Bod,Attila Szepes,Janos Sumegi,Maria Papp,Csaba Gog,Imola Torok,Wei Huang,Qing Xia,Ping Xue,Weiqin Li,Weiwei Chen,Natalia Shirinskaya,Vladimir L. Poluektov,Anna Shirinskaya,Peter Jeno Hegyi,Marian Batovsky,Juan Armando Rodriguez-Oballe,Isabel Miguel Salas,Javier Lopez-Diaz,J. Enrique Dominguez-Munoz,Xavier Molero,Elizabeth Pando,Maria Lourdes Ruiz-Rebollo,Beatriz Burgueno-Gomez,Yu-Ting Chang,Ming-Chu Chang,Ajay Sud,Danielle Moore,Robert Sutton,Amir Gougol,Georgios Papachristou,Yaroslav Mykhailovych Susak,Illia Olehovych Tiuliukin,Antonio Pedro Gomes,Maria Jesus Oliveira,David Joao Aparicio,Marcel Tantau,Floreta Kurti,Mila Kovacheva-Slavova,Stephanie-Susanne Stecher,Julia Mayerle,Goran Poropat,Kshaunish Das,Marco Vito Marino,Gabriele Capurso,Ewa Malecka-Panas,Hubert Zatorski,Anita Gasiorowska,Natalia Fabisiak,Piotr Ceranowicz,Beata Kusnierz-Cabala,Joana Rita Carvalho,Samuel Raimundo Fernandes,Jae Hyuck Chang,Eun Kwang Choi,Jimin Han,Sara Bertilsson,Hanaz Jumaa,Gabriel Sandblom,Sabite Kacar,Minas Baltatzis,Aliaksandr Vladimir Varabei,Vizhynis Yeshy,Serge Chooklin,Andriy Kozachenko,Nikolay Veligotsky,Peter Hegyi
DOI: https://doi.org/10.1016/j.pan.2019.04.003
IF: 3.977
2019-01-01
Pancreatology
Abstract:Background: Unwarranted administration of antibiotics in acute pancreatitis presents a global challenge. The clinical reasoning behind the misuse is poorly understood. Our aim was to investigate current clinical practices and develop recommendations that guide clinicians in prescribing antibiotic treatment in acute pancreatitis. Methods: Four methods were used. 1) Systematic data collection was performed to summarize current evidence; 2) a retrospective questionnaire was developed to understand the current global clinical practice; 3) five years of prospectively collected data were analysed to identify the clinical parameters used by medical teams in the decision making process, and finally; 4) the UpToDate Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system was applied to provide evidence based recommendations for healthcare professionals. Results: The systematic literature search revealed no consensus on the start of AB therapy in patients with no bacterial culture test. Retrospective data collection on 9728 patients from 22 countries indicated a wide range (31-82%) of antibiotic use frequency in AP. Analysis of 56 variables from 962 patients showed that clinicians initiate antibiotic therapy based on increased WBC and/or elevated CRP, lipase and amylase levels. The above mentioned four laboratory parameters showed no association with infection in the early phase of acute pancreatitis. Instead, procalcitonin levels proved to be a better biomarker of early infection. Patients with suspected infection because of fever had no benefit from antibiotic therapy. Conclusions: The authors formulated four consensus statements to urge reduction of unjustified antibiotic treatment in acute pancreatitis and to use procalcitonin rather than WBC or CRP as biomarkers to guide decision-making. (C) 2019 IAP and EPC. Published by Elsevier B.V. All rights reserved.